Accès gratuit
Numéro |
Med Sci (Paris)
Volume 26, Numéro 10, Octobre 2010
|
|
---|---|---|
Page(s) | 803 - 807 | |
Section | Nouvelles | |
DOI | https://doi.org/10.1051/medsci/20102610803 | |
Publié en ligne | 15 octobre 2010 |
- Morris DL, Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 2009 ; 297 : E1247-59. [Google Scholar]
- Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999 ; 341 : 879-84. [Google Scholar]
- Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002 ; 110 : 1093-103. [Google Scholar]
- Capeau J, Magré J, Caron-Debarle M, et al. Human lipodystrophies: genetic and acquired diseases of adipose tissue. Endocr Dev 2010 ; 19 : 1-20. [Google Scholar]
- Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med, 2002 ; 346 : 570-8. [Google Scholar]
- Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002 ; 109 : 1345-50. [Google Scholar]
- Chong AY, Lupsa BC, Cochran EK, Gorden P. Efficacy of leptin therapy in the different forms of human lipodystrophy. Diabetologia 2010 : 53 : 27-35. [Google Scholar]
- Beltrand J, Beregszaszi M, Chevenne D, et al. Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip congenital lipoatrophy. Pediatrics 2007 ; 120 : e291-6. [Google Scholar]
- Unger RH, Clark GO, Scherer PE, Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 2010 ; 1801 : 209-14. [Google Scholar]
- Beltrand J, Lahlou N, Le Charpentier T, et al. Resistance to leptin replacement therapy in Berardinelli-Seip congenital lipodystrophy (BSCL): an immunological origin. Eur J Endocrinol 2010 ; 162 : 1083-91. [Google Scholar]
- Kusakabe T, Tanioka H, Ebihara K, et al. Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet. Diabetologia 2009 ; 52 : 675-83. [Google Scholar]
- Seufert J. Leptin effects on pancreatic beta-cell gene expression and function. Diabetes 2004 ; 53 (suppl 1) : S152-8. [Google Scholar]
- Park S, Ahn IS, Kim da S. Central infusion of leptin improves insulin resistance and suppresses beta-cell function, but not beta-cell mass, primarily through the sympathetic nervous system in a type 2 diabetic rat model. Life Sci 2010 ; 86 : 854-62. [Google Scholar]
- Wang MY, Chen L, Clark GO, et al. Leptin therapy in insulin-deficient type I diabetes. Proc Natl Acad Sci USA 2010 ; 107 : 4813-9. [Google Scholar]
- Chinookoswong N, Wang JL, Shi ZQ. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes 1999 ; 48 : 1487-92. [Google Scholar]
- Miyanaga F, Ogawa Y, Ebihara K, et al. Leptin as an adjunct of insulin therapy in insulin-deficient diabetes. Diabetologia 2003 ; 46 : 1329-37. [Google Scholar]
- Yu X, Park BH, Wang MY, et al. Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc Natl Acad Sci USA 2008 ; 105 : 14070-5. [Google Scholar]
- Koh KK, Park SM, Quon MJ. Leptin and cardiovascular disease: response to therapeutic interventions. Circulation 2008 ; 117 : 3238-49. [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.